[1] Soukup T, Mokrý J, Karbanová J, et al. Mesenchymal stem cells isolated from the human bone marrow: cultivation, phenotypic analysis and changes in proliferation kinetics.Acta Medica (Hradec Kralove). 2006;49(1):27-33.
[2] Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-147.
[3] Forte A, Rinaldi B, Sodano L, et al. Stem cell therapy for arterial restenosis: potential parameters contributing to the success of bone marrow-derived mesenchymal stromal cells. Cardiovasc Drugs Ther. 2012;26(1):9-21.
[4] Sakai D, Mochida J, Iwashina T, et al. Regenerative effects of transplanting mesenchymal stem cells embedded in atelocollagen to the degenerated intervertebral disc. Biomaterials. 2006;27(3):335-345.
[5] Saeed H, Iqtedar M. Aberrant gene expression profiles, during in vitro osteoblast differentiation, of telomerase deficient mouse bone marrow stromal stem cells (mBMSCs). J Biomed Sci. 2015;22(1):11.
[6] Zhao Q, Gregory CA, Lee RH, et al. MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs. Proc Natl Acad Sci U S A. 2015;112(2):530-535.
[7] 张连方,康辉,邓廉夫,等.促进小鼠骨髓间充质干细胞增殖和成骨分化的血管内皮生长因子[J].中国组织工程研究,2014,18(41): 6591-6596.
[8] 范敬静.骨髓间充质干细胞及其向肝样细胞分化的潜能[J].中国组织工程究, 2014,18(28):4578-4582.
[9] Song N, Armstrong AD, Li F, et al. Multipotent mesenchymal stem cells from human subacromial bursa: potential for cell based tendon tissue engineering. Tissue Eng Part A. 2014; 20(1-2):239-249.
[10] Bertolo A, Gemperli A, Gruber M, et al. In vitro cell motility as a potential mesenchymal stem cell marker for multipotency. Stem Cells Transl Med. 2015;4(1):84-90.
[11] Zhou QI, Yang C, Yang P. The Promotional Effect of Mesenchymal Stem Cell Homing on Bone Tissue Regeneration. Curr Stem Cell Res Ther. 2015 Feb 11. [Epub ahead of print]
[12] Guan M, Xu Y, Wang W, et al. Differentiation into neurons of rat bone marrow-derived mesenchymal stem cells. Eur Cytokine Netw. 2014;25(3):58-63.
[13] Izuagie IA, Pelham CJ, Agrawal DK. Synergistic effect of angiotensin II on vascular endothelial growth factor-A- mediated differentiation of bone marrow-derived mesenchymal stem cells into endothelial cells. Stem Cell Res Ther. 2015;6(1):4.
[14] Zemel'ko VI, Kozhukharova IV, Kovaleva ZV, et al. BDNF secretion in human mesenchymal stem cells isolated from bone marrow, endometrium and adipose tissue. Tsitologiia. 2014;56(3):204-211.
[15] Akeda K, An HS, Pichika R, et al. Platelet-rich plasma (PRP) stimulates the extracellular matrix metabolism of porcine nucleus pulposus and anulus fibrosus cells cultured in alginate beads. Spine (Phila Pa 1976). 2006;31(9):959-966.
[16] Raeissadat SA, Rayegani SM, Hassanabadi H, et al. Knee Osteoarthritis Injection Choices: Platelet- Rich Plasma (PRP) Versus Hyaluronic Acid (A one-year randomized clinical trial). Clin Med Insights Arthritis Musculoskelet Disord. 2015;8:1-8.
[17] Liu C, Zhang H. Advances in the research of promoting healing of chronic wound with platelet-rich plasma. Zhonghua Shao Shang Za Zhi. 2014;30(5):433-436.
[18] 文军,李东.富血小板血浆应用于间充质干细胞体外培养的研究进展[J].医学综述,2014,20(19):3473-3475.
[19] Cavallo C, Filardo G, Mariani E, et al. Comparison of platelet-rich plasma formulations for cartilage healing: an in vitro study. J Bone Joint Surg Am. 2014;96(5):423-429.
[20] 武海军,银和平,李树文,等. 密度梯度离心和贴壁筛选法分离培养兔骨髓间充质干细胞的形态学观察[J].中华临床医师杂志, 2012,6(22):7261-7269.
[21] 宫宇,王鸿飞,夏海军,等.全骨髓贴壁接触培养SD大鼠骨髓间充质干细胞[J].中国组织工程研究,2014,18(1):51-56.
[22] 吕敏,裴国献,刘勇,等.富血小板血浆的制备现状及研究进展[J].现代生物医学进展,2013,13(13): 2574-2577,2475.
[23] 张卫兵,洪光祥,康皓. 富血小板血浆对免骨髓间充质干细胞增殖的作用[J].中国组织工程研究与临床康复,2008,12(34): 6639-6642.
[24] Du CH, Li NY, Gao N, et al. A preliminary study on the application of bone marrow stromal cell sheet on the formation of functional tissue-engineered bone in dogs. J Oral Maxillofac Surg. 2013;71(9):1531.e1-1531.e10.
[25] 王宏彬.同种异体骨髓间充质干细胞的研究现状[J].中国组织工程研究,2012,16(23): 4306-4309.
[26] 王月秋,陈伯华.兔椎间盘移植人骨髓间充质干细胞的实验观察[J].中国组织工程研究与临床康复,2010,14(27):4951-4954.
[27] Tian H, Yang S, Xu L, et al. Chondrogenic differentiation of mouse bone marrow mesenchymal stem cells induced by cartilage-derived morphogenetic protein-2 in vitro. J Huazhong Univ Sci Technolog Med Sci. 2007;27(4):429-432.
[28] Song YS, Lee HJ, Park IH, et al. Potential differentiation of human mesenchymal stem cell transplanted in rat corpus cavernosum toward endothelial or smooth muscle cells. Int J Impot Res. 2007;19(4):378-385.
[29] Man Z, Yin L, Shao Z, et al. The effects of co-delivery of BMSC-affinity peptide and rhTGF-β1 from coaxial electrospun scaffolds on chondrogenic differentiation. Biomaterials. 2014; 35(19):5250-5260.
[30] Wu G, Cui Y, Wang YT, et al. Repair of cartilage defects in BMSCs via CDMP1 gene transfection. Genet Mol Res. 2014; 13(1):291-301.
[31] Song N, Armstrong AD, Li F, et al. Multipotent mesenchymal stem cells from human subacromial bursa: potential for cell based tendon tissue engineering. Tissue Eng Part A. 2014; 20(1-2):239-249.
[32] Bertolo A, Gemperli A, Gruber M, et al. In vitro cell motility as a potential mesenchymal stem cell marker for multipotency. Stem Cells Transl Med. 2015;4(1):84-90.
[33] 刘康,白亦光,陈竹,等.兔骨髓间充质干细胞的分离培养及鉴定[J].川北医学院学报,2013, 28(2):103-106.
[34] Wegmeyer H, Bröske AM, Leddin M, et al. Mesenchymal stromal cell characteristics vary depending on their origin. Stem Cells Dev. 2013;22(19):2606-2618.
[35] Sun ZL, Zhang YZ. Effects of high plating densities on in vitro and in vivo differentiation capability of immortalized human mesenchymal stem cells. Zhonghua Yi Xue Za Zhi. 2013; 93(45):3640-3642.
[36] Sreejit P, Dilip KB, Verma RS. Generation of mesenchymal stem cell lines from murine bone marrow. Cell Tissue Res. 2012;350(1):55-68.
[37] Zhang W, Zhang F, Shi H, et al. Comparisons of rabbit bone marrow mesenchymal stem cell isolation and culture methods in vitro. LoS One. 2014;9(2):e88794.
[38] Weibrich G, Kleis WK, Hafner G. Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system. Int J Oral Maxillofac Implants. 2002;17(2):184-190.
[39] Kushida S, Kakudo N, Morimoto N, et al. Platelet and growth factor concentrations in activated platelet-rich plasma: a comparison of seven commercial separation systems. J Artif Organs. 2014;17(2):186-192.
[40] Kim TH, Kim SH, Sándor GK, et al. Comparison of platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factor (CGF) in rabbit-skull defect healing. Arch Oral Biol. 2014;59(5):550-558.
[41] Appel TR, Pötzsch B, Müller J, et al. Comparison of three different preparations of platelet concentrates for growth factor enrichment. Clin Oral Implants Res. 2002;13(5): 522-528. |